BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11686855)

  • 1. Comparison of two methods based on cross-sectional data for correcting corpus uterine cancer incidence and probabilities.
    Merrill RM; Lyon JL; Wiggins C
    BMC Cancer; 2001; 1():13. PubMed ID: 11686855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence corrected hysterectomy rates and probabilities in Utah.
    Merrill RM
    Ann Epidemiol; 2001 Feb; 11(2):127-35. PubMed ID: 11164129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
    Jamison PM; Noone AM; Ries LA; Lee NC; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):233-41. PubMed ID: 23239812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectionally derived hysterectomy prevalence for correcting uterine and ovarian cancer incidence rates and probabilities.
    Merrill R; Lyon J; Wiggins C
    Ann Epidemiol; 2000 Oct; 10(7):464. PubMed ID: 11018384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy.
    Merrill RM; Layman AB; Oderda G; Asche C
    Ann Epidemiol; 2008 Mar; 18(3):253-60. PubMed ID: 18280923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating lifetime and age-conditional probabilities of developing cancer.
    Wun LM; Merrill RM; Feuer EJ
    Lifetime Data Anal; 1998; 4(2):169-86. PubMed ID: 9658774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
    Clarke MA; Devesa SS; Harvey SV; Wentzensen N
    J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
    Rositch AF; Nowak RG; Gravitt PE
    Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States.
    Temkin SM; Kohn EC; Penberthy L; Cronin KA; Rubinsak L; Dickie LA; Minasian L; Noone AM
    Cancer Causes Control; 2018 May; 29(4-5):427-433. PubMed ID: 29497884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008.
    Siegel RL; Devesa SS; Cokkinides V; Ma J; Jemal A
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):25-31. PubMed ID: 23125334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010.
    Stang A; Hawk H; Knowlton R; Gershman ST; Kuss O
    Ann Epidemiol; 2014 Nov; 24(11):849-54. PubMed ID: 25241148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hysterectomy on endometrial carcinoma rates in the United States.
    Sherman ME; Carreon JD; Lacey JV; Devesa SS
    J Natl Cancer Inst; 2005 Nov; 97(22):1700-2. PubMed ID: 16288124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States.
    Merrill RM
    Ann Epidemiol; 2006 Dec; 16(12):880-7. PubMed ID: 17027290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Beavis AL; Gravitt PE; Rositch AF
    Cancer; 2017 May; 123(6):1044-1050. PubMed ID: 28112816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland.
    Ruiz de Azua Unzurrunzaga G; Brewster DH; Wild SH; Sivalingam VN
    Cancer Epidemiol; 2019 Apr; 59():227-231. PubMed ID: 30836220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.
    Clarke MA; Devesa SS; Hammer A; Wentzensen N
    JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
    Doll KM; Winn AN
    Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.
    Redburn JC; Murphy MF
    BJOG; 2001 Apr; 108(4):388-95. PubMed ID: 11305546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010.
    Luoto R; Raitanen J; Pukkala E; Anttila A
    Br J Cancer; 2004 May; 90(9):1756-9. PubMed ID: 15208619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004.
    Wong CA; Jim MA; King J; Tom-Orme L; Henderson JA; Saraiya M; Richardson LC; Layne L; Suryaprasad A; Espey DK
    Cancer Causes Control; 2011 Dec; 22(12):1681-9. PubMed ID: 21984306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.